GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Brightgene Bio-medical Technology Co Ltd (SHSE:688166) » Definitions » Issuance of Stock

Brightgene Bio-medical Technology Co (SHSE:688166) Issuance of Stock : ¥0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is Brightgene Bio-medical Technology Co Issuance of Stock?

Brightgene Bio-medical Technology Co's Issuance of Stock for the three months ended in Mar. 2025 was ¥0 Mil.

Brightgene Bio-medical Technology Co's Issuance of Stock for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0 Mil.


Brightgene Bio-medical Technology Co Issuance of Stock Historical Data

The historical data trend for Brightgene Bio-medical Technology Co's Issuance of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brightgene Bio-medical Technology Co Issuance of Stock Chart

Brightgene Bio-medical Technology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Issuance of Stock
Get a 7-Day Free Trial Premium Member Only - - - - -

Brightgene Bio-medical Technology Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Issuance of Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Brightgene Bio-medical Technology Co Issuance of Stock Calculation

A company may raise cash from issuing new shares. Issuance of Stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Issuance of Stock for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Brightgene Bio-medical Technology Co Issuance of Stock Related Terms

Thank you for viewing the detailed overview of Brightgene Bio-medical Technology Co's Issuance of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.


Brightgene Bio-medical Technology Co Business Description

Traded in Other Exchanges
N/A
Address
Xinghu Street, Industrial Park, Building C25-C28, Bio-Nano Park, No. 218, Suzhou, CHN, 215123
Brightgene Bio-medical Technology Co Ltd is a pharmaceutical company engaged in research, development and production of new drugs and high-end generic drugs. The company develops macrolides, peptides, polysaccharides, heterocycles, azoles, azines, phenyl ethers, tetracyclines, and production of non-pharmaceutical macrolides, peptides, polysaccharides, heterocycles, azoles, azines, benzene Ethers, tetracyclines.

Brightgene Bio-medical Technology Co Headlines

No Headlines